Insider Transactions in Q4 2020 at Catalyst Pharmaceuticals, Inc. (CPRX)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 22
2020
|
Richard J Daly President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,333
+50.0%
|
-
|
|
Dec 22
2020
|
Steve Miller Chief Op. & Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+2.87%
|
-
|
|
Dec 22
2020
|
Patrick J Mcenany Director |
SELL
Payment of exercise price or tax liability
|
Direct |
7,507
-0.16%
|
-
|
|
Dec 22
2020
|
Patrick J Mcenany Director |
BUY
Exercise of conversion of derivative security
|
Direct |
30,833
+0.64%
|
-
|
|
Dec 22
2020
|
Gary Ingenito Chief Med. & Reg. Officer |
SELL
Open market or private sale
|
Direct |
3,668
-25.01%
|
$11,004
$3.45 P/Share
|
|
Dec 22
2020
|
Gary Ingenito Chief Med. & Reg. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
14,666
+50.0%
|
-
|
|
Dec 22
2020
|
Philip H Coelho Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,333
+0.61%
|
-
|
|
Dec 22
2020
|
Charles B O'Keeffe Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,333
+0.24%
|
-
|
|
Dec 22
2020
|
David S Tierney Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,333
+0.43%
|
-
|
|
Dec 22
2020
|
Brian Elsbernd Chief Compliance/Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
14,666
+50.0%
|
-
|
|
Dec 22
2020
|
Donald A Denkhaus Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,333
+0.59%
|
-
|
|
Dec 22
2020
|
Alicia Grande VP, Treasurer and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,571
-0.87%
|
-
|
|
Dec 22
2020
|
Alicia Grande VP, Treasurer and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
14,666
+3.45%
|
-
|